JBM (Healthcare) Limited (2161.HK) HKSE
2.36
-0.03(-1.26%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.36
-0.03(-1.26%)
Currency In HKD
Address
Unit 2303-07, Tower 1
Kwun Tong,
Hong Kong
Phone
852 2267 2178
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
279
First IPO Date
February 05, 2021
| Name | Title | Pay | Year Born |
| Yat Wai Wong | Chief Executive Officer | 3.01M | 1964 |
| Kwong Yip Sum | Executive Chairman of the Board & CEO | 3.13M | 1963 |
| Heung Kwan Cheng | Executive Director | 200,000 | 1962 |
| Chun Leung Yim FCCA | Executive Director | 200,000 | 1962 |
| Chun Kau Yu FCPA | Company Secretary | 0 | 1973 |
| Chui Yee Lo | Marketing Director | 0 | 1969 |
| Kau Lap Lam | Vice President of Finance | 0 | 1987 |
| Hoi Ki Leung | Operation Manager | 0 | 1983 |
JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.